“…Patient/tumors description, main findings, and study characteristics of the whole studies included are summarized in Table 1 . Of the 8 included articles [ 8 , 19 , 20 , 21 , 22 , 23 , 24 , 25 ], 3 were conducted in Italy [ 8 , 19 , 24 ] and 2 in Japan [ 20 , 25 ], while the remaining were from China [ 21 ], Egypt, and Korea [ 22 , 23 ], covering an overall time period between February 2019 and April 2020. Overall, the number of patients included was 1016, varying from 32 to 340 in single experiences, while the prevalence of MIBC ranged from n = 6, 10.3% to n = 62, 50%.…”